Nara Organics
Nara Organics has recently been at the center of a significant health-related controversy, following a botulism outbreak associated with its infant formula products. The outbreak has prompted the U.S. Food and Drug Administration (FDA) to initiate a series of inspections, aiming to identify and address the root cause of the contamination.
As of July 1, 2026, there have been three confirmed cases of patients affected by the contaminated formula. All individuals involved suffered from significant paralysis, necessitating immediate hospitalization. This situation underscores the critical importance of stringent safety measures in the production of infant nutrition products.
Modified: 2026/07/02